In this episode of The Big Question, Barclays Europe CEO, Francesco Ceccato, joins Euronews’ business editor, Angela Barnes, at the World Economic Forum in Davos, Switzerland. The bank boss shares his views on financing the AI boom and the “fragmented” capital markets in Europe.
We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a look at where Relay Therapeutics Inc (NASDAQ:RLAY) stands against the other medical AI stocks.
Barclays Research today released a new Impact Series report, entitled “AI revolution: Meeting massive AI infrastructure demands.” Focused on the US, as the market leader for the technology, Barclays Research finds that AI growth could lead data-centre usage to triple by 2030.
Shares of BigBear.ai Holdings, Inc. (NYSE:BBAI – Get Free Report) gapped down prior to trading on Thursday after an insider sold shares in the company. The stock had previously closed at $4.44, but opened at $4.
Nvidia's AI dominance remains strong, but Barclays warns the semiconductor race is shifting--Marvell, Broadcom, and Lumentum are rising fast.
SoundHound AI, Inc. (NASDAQ:SOUN – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seven ratings firms that are currently covering the company, Marketbeat.com reports.
Let us know your predictions in the comments!Last week, we pitted our special guest - DJ and producer Majestic - against an AI to see who could most accurately predict the results of Premier League
Databricks is now valued at $62bn following its latest round of funding, which it will use to expand and invest in its AI offering.
According to Synergy Research Group, data center M&A activity set a new record in 2024, with deals totaling $57 billion, compared to the previous high of $52 billion in 2022.
The AI-agent cybersecurity startup Alterya has been bought by the blockchain giant Chainalysis for over $100 million, Business Insider has learned.
We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a look at where Boston Scientific Corp (NYSE:BSX) stands against the other medical AI stocks.
Barclays highlights Broadcom (NASDAQ:AVGO), Credo Technology (NASDAQ:CRDO), and Lumentum Holdings (NASDAQ:LITE) as additional AI beneficiaries. The firm upgraded Lumentum to Overweight from ...